Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Human ApoE3, but Not ApoE4, Protects Neurons in the ApoE Knockout Mice

17 June 1999. A 1997 study indicated that Alzheimer's patients who carried one or both alleles that code for the E4 form of apolipoprotein had more severe neurodegeneration than did patients who carried only alleles coding for the E3 form of the protein. This and other evidence has led researchers to propose that ApoE4 makes the brain more susceptible to neurodegenerative diseases such Alzheimer's (as well as to poor outcome after acute insults such as head injury or stroke), while ApoE3, conversely, facilitates repair and regeneration. In the June 15 issue of Journal of Neuroscience, Manuel Buttini, Matthias Orth, Robert Mahley, and colleagues report results in ApoE knockout mice that support these proposals.

The ApoE knockout mice (Apoe[-/-]) lack any form of the gene for ApoE; several groups have reported that the mice suffer age-related neurodegeneration, but other groups failed to find such abnormalities. In this experiment, Buttini and colleagues did find age-related differences between Apoe[-/-] and wildtype mice. They found significantly lower levels of various neuronal markers (synaptophysin, MAP-2, phosphorylated neurofilaments) in the neocortex and/or hippocampus of ApoE[-/-] mice at seven to nine months.

Buttini and his colleagues then inserted genes coding for either human ApoE3 or ApoE4 into the embryos of ApoE[-/-] mice. They ensured that the genes would be expressed only in neurons by attaching them to the neuron-specific enolase promoter. The animals were then studied for resistance to the effects of aging and to exitotoxic CNS damage induced by systemic kainic acid.

The researchers found that mice expressing ApoE4 closely resembled the ApoE[-/-] mice at seven to nine months of age, with significantly lower levels of the neuronal markers in neocortex and in the hippocampus relative to wildtype controls. On the other hand, the mice expressing ApoE3 were spared the age-related degeneration. Similarly, ApoE3 conferred protection from the damage caused by kainic acid, but ApoE4 did not.-Hakon Heimer.

Reference:Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci 1999 Jun 15;19(12):4867-80. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad